Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma: Interim analysis of a phase II trial

This article has no abstract
Epistemonikos ID: fdc98707dae8188c961ca7462f933a239e9596a6
First added on: Feb 11, 2025